IRhom1 is overexpressed in breast cancer (BC) and head and neck cancer, and knockdown (KD) of iRhom1 causes apoptosis or autophagy in epithelial cancer cells, and attenuation of fibrotic stroma formation through inhibiting the endothelial–mesenchymal transition14–16. Here, RHBDF1 is linked to breast cancer.